Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to 0.31.

  • United Therapeutics' Asset Utilization Ratio rose 99.49% to 0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31, marking a year-over-year increase of 99.49%. This contributed to the annual value of 0.4 for FY2024, which is 1240.02% up from last year.
  • As of Q3 2025, United Therapeutics' Asset Utilization Ratio stood at 0.31, which was up 99.49% from 0.3 recorded in Q2 2025.
  • United Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.34 during Q1 2022, with a 5-year trough of 0.24 in Q4 2023.
  • Its 5-year average for Asset Utilization Ratio is 0.31, with a median of 0.32 in 2023.
  • Per our database at Business Quant, United Therapeutics' Asset Utilization Ratio plummeted by 2623.87% in 2023 and then surged by 2194.73% in 2024.
  • Over the past 5 years, United Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.33 in 2021, then decreased by 0.74% to 0.33 in 2022, then dropped by 26.24% to 0.24 in 2023, then grew by 21.95% to 0.29 in 2024, then increased by 6.11% to 0.31 in 2025.
  • Its Asset Utilization Ratio stands at 0.31 for Q3 2025, versus 0.3 for Q2 2025 and 0.3 for Q1 2025.